Thalidomide and its dermatologic uses

Acta Dermatovenerologica Croatica

Volumn 15, Issue 1, 2007, Pages 39-44

  Paghdal, Kapila V ^a   Schwartz, Robert ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Erythema nodosom leprosum; Immunomodulation; Teratogenicity; Thalidomide

Indexed keywords

3 (4 AMINO 1,3 DIHYDRO 1,3 DIOXO 2H ISOINDOL 2 YL)GLUTARIMIDE; LENALIDOMIDE; TEMOZOLOMIDE; THALIDOMIDE;

ACTINIC PRURIGO; ALLERGIC VASCULITIS; APHTHOUS STOMATITIS; CLINICAL TRIAL; CONSTIPATION; DIZZINESS; DRUG MECHANISM; ERYTHEMA NODOSUM LEPROSUM; EXFOLIATIVE DERMATITIS; HUMAN; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; MELANOMA; PERIPHERAL NEUROPATHY; PRURIGO; PRURIGO NODULARIS; PRURITUS; PYODERMA GANGRENOSUM; REVIEW; SEDATION; SIDE EFFECT; TOXIC EPIDERMAL NECROLYSIS; UNSPECIFIED SIDE EFFECT; VEIN THROMBOSIS; WEIGHT GAIN;

DERMATOLOGIC AGENTS; HUMANS; SKIN DISEASES; THALIDOMIDE;

EID: 34247478557     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Wu JJ, Huang DB, Pang KR, Hsu S, Tyring SK. Thalidomide: dermatological indications, mechanisms of action and side effects. Br J Dermatol 2005;153:254-73.
2. Moraes M, Russo G. Thalidomide and its dermatologic uses. Am J Med Sci 2001;321: 321-6.
3. Teo SK. Properties of thalidomide and its analogues: implication for anticancer therapy. AAPS J 2005;7:E14-E19.
4. Faver IR, Guerra SG, Su WPD, el-Azhary R. Thalidomide for dermatology: a review of clinical uses and adverse effects. Int J Dermatol 2005;44:61-7.
5. Gordon JN, Goggin PM. Thalidomide and its derivatives: emerging from the wilderness. Postgrad Med J 2003;79:127-32.
6. Howell E, Johnson SM. Venous thrombosis occurring after initiation of thalidomide for the treatment of cicatricial pemphigoid. J Drugs Dermatol 2004;3:83-5.
7. Klausner JD, Kaplan G, Haslett PAJ. Thalidomide in toxic epidermal necrolysis. Lancet 1999;353:324.
8. Bartlett JB, Micheal A, Clarke IA, Dredge K, Nicholson S, Kristeleit H, et al. Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. Br J Cancer 2004;90:955-61.
9. Sviggum HP, Davis MDP, Rajkumar SV, Dispenzieri A. Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma. Arch Dermatol 2006;142:1298-302.
10. Hoverson AR, Davis MDP, Weenig RH, Wolanskyj AP. Neutrophilic dermatosis (Sweet syndrome) of the hands associated with lenalidomide. Arch Dermatol 2006;142:1070-1.
11. Perri AJ, Hsu S. A review of thalidomide's history and current dermatological applications. Dermatol Online J 2003;9:5.
12. Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB, Sutej PG. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol 2003;139:50-4.
13. Brocard A, Barbarot S, Milpied B, Stalder JF. Thalidomide in the treatment of chronic discoid lupus erythematosus. Ann Dermatol Venereol 2005;132:853-6.
14. Kyriakis KP, Kontochristopoulos GJ, Panteleos DN. Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus. Int J Dermatol 2000;39:218-22.
15. Alfadley A, Al-Hawsawi K, Thestrup-Pedersen K, Al-Aboud K. Treatment of prurigo nodularis with thalidomide: a case report and review of the literature. Int J Dermatol 2003;42:372-5.
16. Hojko-Tomoka M, Vega-Memije M, Cortes-Franco R, Dominguez-Soto L, et al. Diagnosis and treatment of actinic prurigo. Dermatol Ther 2003;16:40-4.
17. Yong-Gee SA, Muir JB. Long-term thalidomide for actinic prurigo. Austral J Dermatol 2001;42:281-3.
18. Camisa C, Popovsky JL. Effective treatment of oral erosive lichen planus with thalidomide. Arch Dermatol 2000;136:1442-3.
19. Reiriz AB, Richter MF, Fernandes S, Cancela AI, Costa TD, Di Leone LP, et al. Phase II study of thalidomide in patients with metastatic malignant melanoma. Melanoma Res 2004;14:527-31.
20. Hwu W, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, et al. Temozolomide plus thalidomide in patients with brain metastases from melanoma. Cancer 2005;103:2590-7.
21. Hecker MS, Lebwohl MG. Recalcitrant pyoderma gangrenosum: treatment with thalidomide. J Am Acad Dermatol 1998;38:490-1.
22. Revuz, J, Guillaume JC, Janier M, Hans P, Marchand C, Souteyrand P, et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 1990;126(7):923-7.
23. Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol 2005;52:500-8.
24. Alioua Z, Hjira N, Oumakhir S, Frikh R, Ghfir M, Rimani M, et al. Thalidomide in adult multisystem Langerhans cell histiocytosis: a case report. Rev Med Interne 2006;27:633-6.
25. rd, Kellman RM, Pincus SH, Gaspari AA. Thalidomide therapy for cicatricial pemphigoid. J Am Acad Dermatol 2002;47:S193-5.
26. Strauss RM, Bate J, Nischal KK, Clayton T, Gooi J, Darling JC, et al. A child with laryngo-onychocutaneous syndrome partially responsive to treatment with thalidomide. Br J Dermatol 2006;155:1283-6.